Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better COVID-19 Stock: Merck or Pfizer?

TheMotleyFool

0 0

It's not surprising that COVID-19 has attracted many of the biggest drugmakers on the planet. Pfizer (NYSE: PFE) launched the best-selling vaccine Comirnaty with the help of its partner, BioNTech. Merck (NYSE: MRK) is likely to soon have the first COVID-19 pill on the market.

Pfizer has delivered greater stock gains than Merck since the beginning of the pandemic. But which is the better COVID-19 stock going forward? Here's how the two pharma stocks stack up against each other.

Image source: Getty Images.

Source Fool.com

Like: 0

PFE

Share